Roles of Bone Modifying Agents in Prostate Cancer and Breast Cancer

Exploring the efficacy of bisphosphonates and denosumab in prostate cancer and the importance of adjuvant bisphosphonates in high-risk postmenopausal women with breast cancer, highlighting the significance of bone modifying agents in managing metastatic diseases.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.

Get the app